Albert Nguyen

Albert Nguyen

Auto-generated profile, based on publicly available information

Albert Nguyen

University of Toronto

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TSTian Sun
Tian Sun
ANAlbert Nguyen
Albert Nguyen
JGJennifer L. Gommerman
Jennifer L. Gommerman
The mammalian intestine is a complex environment that is constantly exposed to Ags derived from food, microbiota, and metabolites. Intestinal dendritic cells (DC) have the responsibility of establishing oral tolerance against these Ags while initiating immune responses against mucosal pathogens. We now know that DC are a heterogeneous population of innate immune cells composed of classical and monocyte-derived DC, Langerhans cells, and plasmacytoid DC. In the intestine, DC are found in organized lymphoid tissues, such as the mesenteric lymph nodes and Peyer’s patches, as well as in the lamina propria. In this Brief Review, we review recent work that describes a division of labor between and collaboration among gut DC subsets in the context of intestinal homeostasis and inflammation. Understanding relationships between DC subtypes and their biological functions will rationalize oral vaccine design and will provide insights into treatments that quiet pathological intestinal inflammation.

6 December 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
CLConglei Li
Conglei Li
ELEvelyn Lam
Evelyn Lam
CPChristian Perez-Shibayama
Christian Perez-Shibayama
LWLesley A. Ward
Lesley A. Ward
JZJianbo Zhang
Jianbo Zhang
JGJennifer L. Gommerman
Jennifer L. Gommerman
Early-life LTβR signaling programs the mesenteric lymph node stromal cell environment, optimizing gut IgA responses in the adult mouse.

11 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAndrzej Chruscinski
Andrzej Chruscinski
FHFlora Y. Y. Huang
Flora Y. Y. Huang
ANAlbert Nguyen
Albert Nguyen
JLJocelyn Lioe
Jocelyn Lioe
LTLaura C. Tumiati
Laura C. Tumiati
HRHeather J. Ross
Heather J. Ross
Autoantibodies directed against endogenous proteins including contractile proteins and endothelial antigens are frequently detected in patients with heart failure and after heart transplantation. There is evidence that these autoantibodies contribute to cardiac dysfunction and correlate with clinical outcomes. Currently, autoantibodies are detected in patient sera using individual ELISA assays (one for each antigen). Thus, screening for many individual autoantibodies is laborious and consumes a large amount of patient sample. To better capture the broad-scale antibody reactivities that occur in heart failure and post-transplant, we developed a custom antigen microarray technique that can simultaneously measure IgM and IgG reactivities against 64 unique antigens using just five microliters of patient serum. We first demonstrated that our antigen microarray technique displayed enhanced sensitivity to detect autoantibodies compared to the traditional ELISA method. We then piloted this technique using two sets of samples that were obtained at our institution. In the first retrospective study, we profiled pre-transplant sera from 24 heart failure patients who subsequently received heart transplants. We identified 8 antibody reactivities that were higher in patients who developed cellular rejection (2 or more episodes of grade 2R rejection in first year after transplant as defined by revised criteria from the International Society for Heart and Lung Transplantation) compared with those who did have not have rejection episodes. In a second retrospective study with 31 patients, we identified 7 IgM reactivities that were higher in heart transplant recipients who developed antibody-mediated rejection (AMR) compared with control recipients, and in time course studies, these reactivities appeared prior to overt graft dysfunction. In conclusion, we demonstrated that the autoantibody microarray technique outperforms traditional ELISAs as it uses less patient sample, has increased sensitivity, and can detect autoantibodies in a multiplex fashion. Furthermore, our results suggest that this autoantibody array technology may help to identify patients at risk of rejection following heart transplantation and identify heart transplant recipients with AMR.

31 December 2015 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
ABA. Bartczak
A. Bartczak
ACA. Chruscinski
A. Chruscinski
MMM. Mendicino
M. Mendicino
HLH. Liu
H. Liu
JZJ. Zhang
J. Zhang
GLG. A. Levy
G. A. Levy
Fibrinogen‐like protein 2 (FGL2) is an immunomodulatory protein that is expressed by regulatory T cells (Tregs). The objective of this study was to determine if recombinant FGL2 (rFGL2) treatment or constitutive FGL2 overexpression could promote transplant tolerance in mice. Although rFGL2 treatment prevented rejection of fully mismatched cardiac allografts, all grafts were rejected after stopping treatment. Next, we generated FGL2 transgenic mice (fgl2Tg) that ubiquitously overexpressed FGL2. These mice developed normally and had no evidence of the autoimmune glomerulonephritis seen in fgl2−/− mice. Immune characterization showed fgl2Tg T cells were hypoproliferative to stimulation with alloantigens or anti‐CD3 and anti‐CD28 stimulation, and fgl2Tg Tregs had increased immunosuppressive activity compared with fgl2+/+ Tregs. To determine if FGL2 overexpression can promote tolerance, we transplanted fully mismatched cardiac allografts into fgl2Tg recipients. Fifty percent of cardiac grafts were accepted indefinitely in fgl2Tg recipients without any immunosuppression. Tolerant fgl2Tg grafts had increased numbers and proportions of Tregs and tolerant fgl2Tg mice had reduced proliferation to donor but not third party antigens. These data show that tolerance in fgl2Tg recipients involves changes in Treg and T cell activity that contribute to a higher intragraft Treg–to–T cell ratio and acceptance of fully mismatched allografts.

13 November 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
ECEric Yixiao Cao
Eric Yixiao Cao
KBKyle Burrows
Kyle Burrows
PCPailin Chiaranunt
Pailin Chiaranunt
APAna Popovic
Ana Popovic
XZXueyang Zhou
Xueyang Zhou
AMArthur Mortha
Arthur Mortha
Immunoglobulin (Ig) A supports mucosal immune homeostasis and host–microbiota interactions. While commensal bacteria are known for their ability to promote IgA, the role of non-bacterial commensal microbes in the induction of IgA remains elusive. Here, we demonstrate that permanent colonization with the protozoan commensal Tritrichomonas musculis (T.mu) promotes T cell–dependent, IgA class-switch recombination, and intestinal accumulation of IgA-secreting plasma cells (PC). T.mu colonization specifically drives the expansion of T follicular helper cells and a unique ICOS+ non-Tfh cell population, accompanied by an increase in germinal center B cells. Blockade of ICOS:ICOSL co-stimulation or MHCII-expression on B cells is central for the induction of IgA following colonization by T.mu, implicating a previously underappreciated mode of IgA induction following protozoan commensal colonization. Finally, T.mu further improves the induction of IgA-secreting PC specific to orally ingested antigens and their peripheral dissemination, identifying T.mu as a “natural adjuvant” for IgA. Collectively, these findings propose a protozoa-driven mode of IgA induction to support intestinal immune homeostasis.

21 November 2025 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
ANAlbert A. Nguyen
Albert A. Nguyen
LFLogan Fisher
Logan Fisher
JAJennifer S. Y. Ahn
Jennifer S. Y. Ahn
MZMichelle Zuo
Michelle Zuo
TPTyler Park
Tyler Park
CBChrysothemis C. Brown
Chrysothemis C. Brown